Treatment of persistent large cystic lesions of the humerus with vascularized fibular grafts
Mehmet Ümit Çetin1, İsmail Bülent Özçelik2
1Department of Orthopedics and Traumatology, Tekirdağ Namık Kemal University, Tekirdağ, Türkiye
2Department of Orthopedics and Traumatology, Yeni Yüzyıl University Gaziosmanpaşa Hospital, Istanbul, Türkiye
Keywords: Cystic lesions, humerus, vascularized fibula graft.
Objectives: In this study, we aimed to evaluate the short-to-midterm results of the resection and reconstruction of large cystic lesions of the humerus.
Patients and methods: Eight male patients (median age: 22.9±10.4 years; range, 12 to 42 years) with large cystic lesions of the humerus operated between January 2017 and December 2019 were retrospectively analyzed. The age of the patients, their previous treatments and follow-up periods, the size and location of the cysts, postoperative functional scores, presence of a union, recurrence of the cyst, and graft resorption were examined.
Results: The mean follow-up was 42.8±7.5 (range, 34 to 54) months. Preoperatively, the mean length of the cystic lesions was 15.1±2.6 (range, 10 to 18) cm. At the final follow-up, the patients had a normal range of shoulder flexion-extension, internal rotation-external, abduction-adduction, and elbow flexion-extension, pronation-supination. The patients had a mean DASH score of 1.13±1.1 (range, 0 to 3.3) and MSTS score of 28.75±1.8 (range, 26 to 30) postoperatively. Complications such as pseudoarthrosis, graft resorption, or cyst recurrence were not observed in any of the patients.
Conclusion: Although the risk of recurrence is low in small cystic lesions of the humerus, it increases as the size of the lesion increases. This reconstruction technique using vascularized fibular grafts, which we applied, seems to be extremely successful in ensuring biological healing and preventing recurrence and complications in patients with large cystic lesions of the humerus.
Citation: Çetin MÜ, Özçelik İB. Treatment of persistent large cystic lesions of the humerus with vascularized fibular grafts. Jt Dis Relat Surg 2022;33(2):426-434.
The study protocol was approved by the Tekirdağ Namık Kemal University Ethics Committee (date/no: 30.03.2021/2021.73.03.13). The study was conducted in accordance with the principles of the Declaration of Helsinki.
A written informed consent was obtained from each patient.
Data Sharing Statement: The data that support the findings of this study are available from the corresponding author upon reasonable request.
Idea/concept: İ.B.Ö.; Design: M.Ü.Ç.; Control/supervision: İ.B.Ö.; Data collection and/or processing: M.Ü.Ç.; Analysis and/or interpretation: M.Ü.Ç.; Literature review: M.Ü.Ç.; Writing the article: M.Ü.Ç.; Critical review: İ.B.Ö.; References and fundings: M.Ü.Ç.; Materials: İ.B.Ö.
The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
The authors received no financial support for the research and/or authorship of this article.